Téthys Invest

Téthys Invest is the investment arm of Téthys, the holding company of the Bettencourt-Meyers family, who are the largest shareholders of L'Oréal. Established in March 2016 by Françoise Bettencourt Meyers and Jean-Pierre Meyers, Téthys Invest focuses on making direct, long-term investments in entrepreneurial projects. The firm operates as a single-family office, managing a diversified portfolio alongside the family's significant stake in the global beauty giant L'Oréal.

The firm's investment strategy emphasizes diversification across various sectors, primarily targeting French companies, though it also includes some international ventures. Téthys Invest seeks to partner with promising businesses, providing capital for growth and supporting their strategic development. Its portfolio reflects a commitment to sectors such as healthcare, education, consumer goods, fashion, insurance, and information technology.

Notable investments by Téthys Invest include stakes in prominent companies like Elsan, a major private hospital network in France, and Sebia, an in vitro diagnostics company. The firm has also invested in Galileo Global Education, a leader in private education, and the French fashion brand Sézane. Further diversifying its holdings, Téthys Invest has backed French animal vaccine and drugmaker Ceva Santé Animale, French insurer April Sante Prevoyance, and the IT company Septeo SAS. The firm also holds a stake in the American clothing label, The Row.

Téthys Invest is led by CEO Alexandre Benais, with Françoise Bettencourt Meyers serving as Chair of the parent company Téthys, and Jean-Pierre Meyers as its CEO. Cyrielle Villepelet was appointed Managing Director in March 2023, bringing expertise in consumer goods, omnichannel strategies, and retail. The firm's approach is characterized by a degree of privacy, favoring long-term, relationship-based engagements within established networks in the French business and financial community.